BAMCO Inc
GH icon

BAMCO Inc’s Guardant Health GH Stock Holding History

BAMCO Inc’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48M Sell
16,500
-15,500
-48% -$1.69M ﹤0.01% 276
2026
Q1 		$2.96M Buy
+32,000
New +$3.21M 0.01% 269
2023
Q2 		– Sell
-52,319
Closed -$1.23M – 350
2023
Q1 		$1.23M Sell
52,319
-185,415
-78% -$5.3M ﹤0.01% 316
2022
Q4 		$6.47M Sell
237,734
-346,316
-59% -$15.8M 0.02% 256
2022
Q3 		$31.4M Sell
584,050
-4,595
-0.8% -$236K 0.1% 149
2022
Q2 		$23.7M Sell
588,645
-337,009
-36% -$16.7M 0.08% 188
2022
Q1 		$61.3M Sell
925,654
-204,755
-18% -$14M 0.15% 122
2021
Q4 		$113M Buy
1,130,409
+360
+0% +$37.2K 0.24% 76
2021
Q3 		$141M Sell
1,130,049
-9,730
-0.9% -$1.16M 0.32% 68
2021
Q2 		$142M Buy
1,139,779
+231
+0% +$31.1K 0.32% 73
2021
Q1 		$174M Buy
1,139,548
+49,565
+5% +$7.49M 0.43% 53
2020
Q4 		$140M Buy
1,089,983
+31,218
+3% +$3.59M 0.35% 64
2020
Q3 		$118M Buy
1,058,765
+121,088
+13% +$11.1M 0.36% 65
2020
Q2 		$76.1M Buy
937,677
+548,518
+141% +$44.2M 0.28% 79
2020
Q1 		$27.1M Buy
389,159
+67,191
+21% +$5.16M 0.13% 125
2019
Q4 		$25.2M Buy
321,968
+8,629
+3% +$622K 0.1% 151
2019
Q3 		$20M Sell
313,339
-93,012
-23% -$8.19M 0.08% 162
2019
Q2 		$35.1M Sell
406,351
-32,292
-7% -$2.47M 0.14% 134
2019
Q1 		$33.6M Sell
438,643
-126,355
-22% -$7M 0.14% 140
2018
Q4 		$21.2M Buy
+564,998
New +$20.8M 0.11% 159

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BAMCO Inc's GH Position: Q2 2026 in Review

BAMCO Inc reduced its Guardant Health (GH) stake by 48% in Q2 2026, selling an estimated $1.69M and leaving 16,500 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #276.

BAMCO Inc first reported a position in GH in Q4 2018 and has held it in 20 quarters since. The position peaked at $174M in Q1 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • BAMCO Inc held 16,500 shares of Guardant Health worth $2.48M as of Q2 2026.
  • BAMCO Inc sold 15,500 Guardant Health shares in Q2 2026, an estimated $1.69M.
  • Guardant Health made up ﹤0.01% of BAMCO Inc's portfolio in Q2 2026, its #276 holding.
  • BAMCO Inc first reported a position in Guardant Health in Q4 2018 and has held it in 20 quarters since.
  • BAMCO Inc's Guardant Health position peaked at $174M in Q1 2021.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.